Literature DB >> 9928897

The cerebrospinal fluid oxidized NO metabolites, nitrite and nitrate, in Alzheimer's disease and vascular dementia of Binswanger type and multiple small infarct type.

H Tohgi1, T Abe, K Yamazaki, T Murata, C Isobe, E Ishizaki.   

Abstract

The concentration of the nitric oxide (NO) metabolites nitrite (NO2-) and nitrate (NO3-) in the cerebrospinal fluid from patients with Alzheimer's disease (AD), vascular dementia of the Binswanger type (VDBT) or multiple small infarct type (MSID), and controls were determined using high performance liquid chromatography. The nitrite concentration was significantly higher in VDBT/MSID patients than in controls (p < 0.005). The nitrate concentration and the combined nitrite and nitrate concentration was significantly higher in both AD (p < 0.05) and VDBT/MSID (p < 0.001) patients than in controls, with these concentrations being significantly greater in VDBT/MSID than AD patients (p < 0.005). The combined nitrite and nitrate concentration significantly decreased as the severity of dementia progressed in AD (rs=0.70, p < 0.01), but remained elevated in all stages of VDBT/MSID. These results suggest that NO production or oxidation in the brain increases in the early stage of AD and then decreases as neuronal cell loss progresses, but increases throughout the course of disease in VDBT/MSID, which may in part contribute to neuronal degeneration in both conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9928897     DOI: 10.1007/s007020050131

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  5 in total

Review 1.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 2.  The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches.

Authors:  Han-Yan Zhu; Fen-Fang Hong; Shu-Long Yang
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

Review 3.  Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects.

Authors:  Regina F Nasyrova; Dmitriy V Ivashchenko; Mikhail V Ivanov; Nikolay G Neznanov
Journal:  Front Physiol       Date:  2015-05-11       Impact factor: 4.566

4.  Strategic Modification of Gut Microbiota through Oral Bacteriotherapy Influences Hypoxia Inducible Factor-1α: Therapeutic Implication in Alzheimer's Disease.

Authors:  Laura Bonfili; Chunmei Gong; Francesca Lombardi; Maria Grazia Cifone; Anna Maria Eleuteri
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

5.  Effects of L-NAME, a non-specific nitric oxide synthase inhibitor, on AlCl3-induced toxicity in the rat forebrain cortex.

Authors:  Ivana D Stevanović; Marina D Jovanović; Ankica Jelenković; Miodrag Colić; Ivana Stojanović; Milica Ninković
Journal:  J Vet Sci       Date:  2009-03       Impact factor: 1.672

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.